Zydus Lifesciences Limited-Walk-In Interview for QC/ Production (API) On 18th Feb’ 2023
Job Description
Walk-In Interview for QC/ Production (API) On 18th Feb’ 2023 @ Zydus Lifesciences LimitedDepartment: QC/ Production (API)
Designation: Executive/ Sr. Executive
Qualification: MS/ M.Sc, B.Sc
Experience: 03 to 06+ years
Job Location: Vadodara
No of Openings: 10
JD: We are recruiting for our API Production Plant Located at Dabhasa, Nr. Vadodara
- Production (API) : Executive / Sr. Executive
- The incumbent should be B.Sc/ M.Sc (Chemistry) with 3 to 6 years of relevant experience in API Production.
- Should have exposure in reactors, centrifuges and clean room equipment with sound knowledge in cGMP and SOPs.
- Should have exposure to regulatory requirement of documentation.
- Adherence to Quality, Safety, Health and Environment measures and cGMP norms.
- Quality Control (API): Executive/ Sr. Executive
- The incumbent should be B.Sc/ M.Sc (Chemistry) with 3 to 6 years of relevant experience (Pharmaceutical Only) in analyse the Raw Materials, In -Process and intermediates finished product and Stability samples.
- Expertise in handling HPLC, GC, UV, IR, KF, Melting point etc. Preparation of STP / SPC / SOP for QC documentation on a routine basis.
- Ensure the compliance, Safety and 100% Good laboratory Practices.
- Having aware of the current pharma procedure of cGMP, GDP, GCP and GLP practices follows in QC laboratory.
Desired Candidates Profile:
•Candidates to have exposure in Pharmaceutical Company (API plant) and regulatory requirements of Documentation and cGMP/ GLP
•Interested Candidates may walk-in for an interview along-with their updated CVs , Salary Slip and relevant documents as per the schedule.
Date : 18th Feb’ 2022
Time: 10:00 AM to 04:00 PM
Venue:
Zydus API Park, Zydus Lifesciences Ltd., (Formerly known as Cadila Healthcare Ltd), Behind Bright Day CBSC School, Next to Kishan Classic , Vasna Bhayli Canal Road, Vadodara
Contact: D K Patel
Zydus Lifesciences Limited-Walk-In Interview for QC/ Production (API) On 18th Feb’ 2023

No comments: